Form 8-K - Current report:
SEC Accession No. 0001048477-23-000041
Filing Date
2023-11-01
Accepted
2023-11-01 16:09:44
Documents
14
Period of Report
2023-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20231101.htm   iXBRL 8-K 25302
2 EX-99.1 earningsrelease-01nov23ex9.htm EX-99.1 318567
6 GRAPHIC bmrnlogoa01.jpg GRAPHIC 3615
  Complete submission text file 0001048477-23-000041.txt   504786

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20231101.xsd EX-101.SCH 2001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20231101_lab.xml EX-101.LAB 24134
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20231101_pre.xml EX-101.PRE 12603
8 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20231101_htm.xml XML 2712
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 231368310
SIC: 2834 Pharmaceutical Preparations